Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.

REACH

Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content greater than 18 % by weight

EC number: 926-771-1 | CAS number: -

Life Cycle description
Uses advised against

Toxicological information

Endpoint summary

Administrative data

Key value for chemical safety assessment

Additional information

Long-term inhalation carcinogenicity toxicity studies with FMMVF fibres are presented in section 7.7 and 7.5.3. Inhalation exposure to FMMVF fibres induced inflammation of the lungs of rats. No pulmonary or mesothelial neoplasms were observed in the animals exposed to FMMVF. The incidence fibrosis was similar to control for FMMVF. Furthermore FMMVF fibres are inorganic fibres, whose physicochemical properties suggest a low potential to cross biological membranes, making it unlikely that a mutagenic effect would be found in bacteria or in mammalian cells. There is sufficient evidence to assess FMMVF fibres as not mutagenic. Thus, mutagenicity studies are waived because they are scientifically unjustified.

Short description of key information:
It is assessed that FMMVF fibres do not possess mutagenic properties, neither in bacteria nor in mammalian cells. FMMVF fibres shall not be classified as mutagenic according to the criteria in Council Directive 67/548/EEC and Regulation (EC) 1272/2008.

Endpoint Conclusion: No adverse effect observed (negative)

Justification for classification or non-classification

Mutagenicity studies in bacteria and mammalian cells are waived. The justification is that long-term inhalation studies show that FMMVF fibres did not show carcinogenic potential neither in the lungs or pleura. Furthermore, the physicochemical properties of FMMVF fibres suggest low potential to cross biological membranes, making it unlikely that a mutagenic effect would be found in bacteria or in mammalian cells. FMMVF fibres are assessed to be non-mutagenic, and shall not be classified as mutagenic according to the criteria in Council Directive 67/548/EEC and Regulation (EC) 1272/2008.

Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.